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The synthesis and characterization of title complexes of the ligand Quinolino[3,2-b]benzodiazepine (QBD) and Quinolino[3,2-
b]benzoxazepine (QBO)arereported.Thecomplexes havebeencharacterizedbyelementalanalysis,molarconductance, magnetic
studies, IR, 1H NMR, and UV-visible studies. They have the stoichiometry [ML2C12], where M=Co(II)/Ni(II), L=QBD/QBO,
and [MLC12], where M=Zn(II)/Cd(II), L=QBD/QBO. The antibacterial and antifungal activity of the metal complexes has been
investigated. The complexes were found to have higher antimicrobial activity than the parent ligand.
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1. INTRODUCTION
Quinoline derivatives represent the major class of heterocy-
cles, and a number of preparations have been known since
thelate1980s.Thequinolineskeletonisoftenusedforthede-
sign of many synthetic compounds with diverse pharmaco-
logical properties. Dynemicin A and Streptonigrin are natu-
rallyoccurringmembersoftheclassofantitumorantibiotics,
whose syntheses are based on the utilization of preformed
quinoline derivatives [1]. The 8-(diethylaminohexylamino)-
6-methoxy-4-methyl-quinoline is highly eﬀective against the
protozoan parasite Trypanosoma cruzi, which is the agent of
Chagasdisease[2]andthe2-(2-methylquinolin-4-ylamino)-
N-phenylacetamide is more active than the standard an-
tileishmanial drug sodium antimony gluconate [3]. The cen-
tipede, Scolopendra Subspinipes mutilalns L. KOCH, which
is found to contain 3,8-dihydroxyquinoline called Jineol
has been prescribed for tetanus and childhood convulsions
[4]. This drug has also been used for many other clini-
cal purposes, such as the treatment of acute heart attack
and as a toxicide in Korea [5]. Cryptolepine (5-methyl-5H-
indolol[3,2-b]quinoline)-majorCryptolepissanguinolentaal-
kaloid displays a plenty of pharmacological eﬀects, such as
antimuscarinic, noradrenergic receptor antagonistic, anti-
hypertensive, vasodilative, antithrombotic, antipyretic, and
anti-inﬂammatory properties. Neocryptolepine and cryp-
tolepine derivatives reveal antiplasmodial, antitrypanoso-
mal,andﬁrstofall,cytotoxicactivities[6–8].Quinolinecon-
taining drugs, particularly 4-aminoquinolines, have a long
and successful history as antimalarials [9, 10].
2. MATERIALS AND METHODS
2.1. Analyticalmethods
All the chemicals used in the present study are of AR grade.
2-Chloro-3-quinolinecarbaldehyde (Sigma-Aldrich Chemie,
Germany), 2-aminophenol (S.D. Fine Chem Ltd, India), and
o-Phenylenediammine (S.D. Fine Chem Ltd, India) were
used. The metal contents of the complexes were determined
by complexometric titrations and gravimetric estimations.
The molar conductivities in DMF (10−3 M) at room temper-
ature were measured using an Equiptronics digital conduc-
tivity meter. Magnetic susceptibilities of the solid complexes
were measured employing Gouy balance at room tempera-
ture (28 ± 2◦C) using Hg[Co(CNS)4], that is, mercury(II)
tetrathiocyanato cobaltate(II), as a calibrant for standardiz-
ing the Gouy tube.2 Bioinorganic Chemistry and Applications
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Scheme 1: Preparation of Quinolino[3,2-b]benzodiazepine(QBD).
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Scheme 2: Preparation of Quinolino[3,2-b]benzoxazepine(QBO).
2.2. Spectralmeasurements
The IR spectra of ligand and its metal complexes were
recorded on a Shimadzu FTIR-8400S spectrometer with KBr
pellets in the region 250–4000cm−1. JEOL 60MHz spec-
trometer was used for recording the proton NMR spec-
tra employing TMS as internal reference and DMSO-d6
as solvent. UV-visible spectra were measured on a Shi-
madzu double beam spectrophotometer using N,N’-dimeth-
ylformamide as a solvent at 10−3 M concentration.
3. EXPERIMENTAL
3.1. SynthesisofligandQBDbymicrowaveirradiation
2-Chloro-3-quinolinecarbaldehyde (0.958g, 5mmo1) dis-
solved in small amount of acetic acid was taken in a 100ml
borosil beaker. o-Phenylenediammine (0.541g, 5mmol) and
a pinch of potassium iodide were then added. The mix-
ture was irradiated in a microwave oven for about 10 min-
utes. The product obtained was poured into ice-cold wa-
ter, the solid separated was ﬁltered, dried, and recrystallized
(Scheme 1).
3.2. SynthesisofligandQBObymicrowaveirradiation
Mixture of 2-aminophenol (0.11g, 1mmol), KOH (0.057g,
1mmol), and 2ml of DMSO were taken in a 100ml
borosil beaker. 2-Chloro-3-quinolinecarbaldehyde (1mmol,
0.192g) and a pinch of KI were then added. The mixture was
irradiated for about two minutes in a microwave oven. The
product obtained was then hydrolyzed by pouring into ice-
coldwater.Theﬁnalproductseparatedasasolidonacidiﬁca-
tion with dilute HCl was then ﬁltered and dried (Scheme 2).
3.3. SynthesisofCobalt(II)andNickel(II)complexes
ofQBDandQBO
The ligand (10mmol) was dissolved in a dry methanol
(50ml). A solution of the metal chloride (5mmol) in
methanol (50ml) was then added dropwise to the ligand so-
lutionundernitrogengaswithcontinuousstirring. Themix-
ture was reﬂuxed for about 5 hours. The resulting precipitate
was ﬁltered oﬀ and washed with methanol. The precipitate
was redissolved in ethanol on a water bath and the ethanol
was slowly evaporated. Further, slow evaporation of the so-
lution at room temperature resulted in the formation of col-
ored compound.
3.4. SynthesisofCadmium(II)andZinc(II)
complexesofQBDandQBO
The ethanolic solution of a ligand (0.5mmol) was slowly
added to a 50ml solution of metal chloride (0.5mmol) in
ethanol with continuous stirring. The reaction mixture was
warmed on a water bath at 70 to 80◦C for about 1 hour. The
precipitate obtained was ﬁltered, washed several times with
absolutealcohol,ﬁnallywithether,and thendried overfused
CaCl2.
4. RESULTS AND DISCUSSION
The complexes are microcrystalline colored powder, stable at
room temperature, and are soluble in DMF and DMSO. The
elementalanalysesweresatisfactory,showthatthecomplexes
have a ligand to metal ratio of 1 : 2 and 1 : 1, and have the
general formula [ML2Cl2], where M=Co(II) or Ni(II), and
[MLCl2], where M=Zn(II) or Cd(II); L=QBD or QBO. The
molar conductance value (13.31–25.2mhos cm2 mol−1) in-
dicates the nonelectrolytic nature of the complexes (Table 1).B. Basavaraju et al. 3
Table 1: Analytical and physical data (calculated values are in parentheses).
Compound Yield
(%)
Found (Calcd) (%)
Molar
conductiv-
itymhos
cm2 mol−1
Magnetic
moment μeﬀ
BM
Mol.Wt.
found
(Calcd)
CHNM C l
QBD 78 78.25 4.36 17.00 ——— — 241.25
(78.38) (4.48) (17.13) (245.27)
QBO 81 78.01 4.23 11.32 ——— 240.32
(78.06) (4.06) (11.38) (246.26)
[Co(QBD)2Cl2]8 5 62.14 3.18 13.44 9.16 11.38 14.8 4.41 624.56
(62.17) (3.23) (13.58) (9.53) (11.46) (620.39)
[Ni(QBD)2Cl2]8 5 62.24 3.14 13.39 9.36 11.25 18.9 2.94 625.12
(62.09) (3.23) (13.57) (9.48) (11.45) (620.15)
[Cd(QBD)Cl2]8 1 44.78 2.20 9.68 26.18 16.48 13.31 — 425.13
(44.94) (2.33) (9.82) (26.29) (16.58) (428.59)
[Zn(QBD)Cl2]7 7 50.72 2.58 11.10 17.08 18.58 14.52 — 378.46
(50.50) (2.62) (11.03) (17.18) (18.63) (381.54)
[Co(QBO)2Cl2]8 5 61.42 3.16 9.2 9.22 11.32 25.2 4.83 648.35
(61.77) (3.21) (9.0) (9.47) (11.39) (622.36)
[Ni(QBO)2Cl2]8 3 61.49 3.05 9.00 9.24 11.25 25.7 3.01 618.25
(61.70) (3.20) (9.20) (9.40) (11.40) (622.12)
[Cd(QBO)Cl2]8 0 44.59 2.34 6.42 26.08 16.41 15.84 — 426.61
(44.73) (2.35) (6.52) (26.17) (16.51) (429.58)
[Zn(QBO)Cl2]7 3 50.26 2.51 7.25 17.06 18.35 16.75 — 378.76
(50.23) (2.63) (7.32) (17.09) (18.53) (382.6)
4.1. Electronicandreﬂectancespectra
The Co(II) complexes exhibit three bands in the visible
region 13310–14250cm−1, 14810–14988cm−1, and 16425–
16431cm−1 pertaining to 4T1g(F) → 4T2g(F) (ν1), 4T1g(F)
→ 4A2g(F) (ν2), and 4T1g(F) → 4T1g(P) (ν3) transitions,
respectively. These electronic spectral data were consistent
with high-spin octahedral conﬁguration around Co(II) ion
[11, 12]. The electronic spectra of Ni(II) complexes of
QBD and QBO show two bands in the region 12610–
16260cm−1and 23256–28011cm−1 due to 3A2g(F) → 3T1g(F)
(ν2)a n d3A2g(F) → 3T1g(P) (ν3) transitions, respectively, that
commensurate with octahedral stereochemistry [13]. The
reﬂectance spectra is identical for both Zn(II) and Cd(II)
complexes. The spectra of the complexes do not indicate
lowest energy 3A2g → 3T2g transition. The Zn(II) com-
plex shows two week low energy bands at ∼15155cm−1 and
∼19500cm−1. This is due to metal ligand charge transfer
process ascribed to a charge transfer from d orbital of the
metal to the π∗ system of the ligand [14–16]. The low-
energy bands are in the position typically found for square
planerconﬁgurationandmaybeassignedto 2B1g → 2A1g and
2B1g → 2Eg transition, respectively. These complexes also ex-
hibit more intense band at ∼37000cm−1 which corresponds
to intra ligand molecular charge transfer within the ligand
that are assigned to n → π∗ transitions. The absence of d-d
bands in these complexes at longer wavelength is quite rea-
sonable since the metal ion has ﬁlled d-sub shells where d-
d transitions are highly forbidden [17, 18]. By considering
these data, the tetrahedral geometry has been proposed for
Cd(II)[19]andsquareplanargeometryforZn(II)complexes
[20, 21].
4.2. Magneticmoments
The room temperature magnetic moment value (Table 1)
supports octahedral geometry for Co(II) and Ni(II) com-
plexes.ThecomplexesZn(II)andCd(II)arediamagneticdue
to the unavailability of unpaired electrons [11–13, 19–21].
4.3. IRspectra
The IR spectra of complexes are compared with that of free
ligands to determine the changes that might have taken place
during complexation. The important bands and assignments
of ligands and their complexes are summarized in Table 2.
The results indicate that the ligands are bidentate [22–28]i n
nature.
The free ligand QBD exhibits strong bands at 1658 and
3330cm−1 due to C=Na n d−NH groups, respectively. In
the IR spectra of complexes, these bands shift (10–35cm−1)
towards the lower energies when compared with free lig-
ands. The characteristic absorptions at 1650 and 1022cm−1
in QBO were assigned to the stretching vibrations of ν(C=N)4 Bioinorganic Chemistry and Applications
Table 2: IR and 1H NMR spectral data.
Compound Infrared spectral data 1H NMR spectral data (δ,p p m )
ν(C=N) ν(NH) ν(COC) ν M−N ν M−X
QBD 1658 3330 — — — 10.65 (s, 1H, NH), 7.2–7.8 (m, 9H, Ar−H),
8.4 (s, 1H, H−C=N),
QBO 1651 — 1022 — — 8.3 (s, 1H, H−C=N),
7.1–8.0 (m, 9H, Ar−H)
[Co(QBD)2Cl2] 1615 3320 — 440 350 10.95 (s, 1H, NH), 7.2–8.8 (m, 9H, Ar−H),
8.4 (s, 1H, H−C=N),
[Co(QBO)2Cl2] 1615 — 995 458 368 8.3 (s, 1H, H−C=N),
7.5–8.9 (m, 9H, Ar−H)
[Ni(QBD)2Cl2] 1620 3310 — 467 250 10.90 (s, 1H, NH), 7.2–8.8 (m, 9H, Ar−H),
8.4 (s, 1H, H−C=N),
[Ni(QBO)2Cl2] 1631 — 996 449 264 8.3 (s, 1H, H−C=N),
7.5–8.9 (m, 9H, Ar−H)
[Zn(QBD)Cl2] 1625 2990 — 428 348 10.90 (s, 1H, NH), 7.2–7.8 (m, 9H, Ar−H),
8.4 (s, 1H, H−C=N),
[Zn(QBO)Cl2] 1615 — 1002 432 350 8.3 (s, 1H, H−C=N),
7.5–8.9 (m, 9H, Ar−H)
[Cd(QBD)Cl2] 1610 3300 — 432 348 10.85 (s, 1H, NH), 7.2–7.8 (m, 9H, Ar−H),
8.4 (s, 1H, H−C=N),
Cd(QBO)Cl2] 1610 — 998 428 360 8.3 (s, 1H, H−C=N),
7.1–8.0 (m, 9H, Ar−H)
and ν(COC) groups, respectively. In the complexes, these vi-
brations shift to lower regions by 10–25cm−1. The shift of
these bands in complexes suggests the coordination of nitro-
gen of quinoline ring and oxygen atom of azepine ring of lig-
and to metal ions. The bonding of metal ion to the ligands
through N, N in QBD and N, O atoms in QBO was further
supported by the presence of new bands in the region 328–
375cm−1 due to ν(M−N) and ν(M−O) vibrations [29–31].
4.4. 1HNMRspectra
The above binding pattern is further supported by proton
magnetic resonance spectral studies and chemical shift val-
ues presented in Table 2.T h e1H NMR spectra of ligand
QBD exhibits a singlet at 10.80 δ (s, N−H) and 8.6 δ (s,
H−C=N).Thespectraofcomplexesslightlychangedascom-
pared to those of corresponding ligand, and the signals ap-
peared downﬁeld, as expected, due to the coordination of ni-
trogen atoms to the metal ion [32–37]. 1HN M Rs p e c t r u m
of QBO ligand showed signals at δ 8.4 (s, 1H, H−C=N), 7.3–
8.0 (m, 11H, Ar−H), and 2.6 (s, 3H, CH3). In the spectra of
complexes, all signals remained in the same position except
the signal of H−C=N. This is probably due to the coordinat-
ing eﬀect of azepine oxygen atom.
5. BIOLOGICAL STUDIES
5.1. Antibacterialactivity
The ligands and their Co(II), Ni(II), Cd(II) and Zn(II) com-
plexesweretestedfortheinvitroantibacterialactivityagainst
P. aerugenosa (gram-negative) and S. aureus (gram-positive)
bacteria by employing paper disc method [38–41]. The an-
tibacterial activity was estimated on the basis of the size of
inhibition zone formed around the paper discs on the seeded
agarplates.Foreachconcentration,themeandiameter(mm)
of inhibition zone developed was calculated. The strepto-
mycin (100mg) was used as a standard and DMF solvent was
also put to know the activity of solvent.
5.2. Antifungalactivity
The antifungal studies of ligands and its metal complexes
were tested on fungal strains namely, C. albicans, A. ﬂavus,
and A. niger in growth media by using Batemann poisoned-
food technique [42, 43]. A known weight of the compound
was dissolved in DMF in suitably labeled sterile test tubes
to get a ﬁnal concentration of 0.1, 0.2, and 0.3%. The ster-
ile medium, sterile ligand, and metal complex solution were
mixedundersterileconditionsandallowedforsolidiﬁcation.
The Fluconazole (100mg) was used as a standard and DMF
solvent was also put to know the activity of solvent.
The test fungi were taken as 2 mm discs from 10 days old
pure colonies and placed at the center of petri dishes con-
taining nutrient medium. The experiment was carried out
in four replicates per treatment, and incubation was carried
out at 30◦C for 72 hours. The radial growth of colony was
recorded after 96 hours of incubation and mean diameter of
mycelial growth in each treatment was recorded. The aver-
age percentage inhibition was calculated on the growth me-
diacomparedtotherespectivecontrolsusingexpression[44]
I = (C-T) × 100/C, where I = percentage inhibition, C = av-
erage diameter of fungal growth on the control plates, andB. Basavaraju et al. 5
Table 3: Antimicrobial activities.
Compound Inhibition zone of bacterial growth (mm) Percentage inhibition of fungicidal growth
P. aerugenosa S. aureus C. albicans A. niger A. ﬂavus
0.1% 0.2% 0.3% 0.1% 0.2% 0.3% 0.1% 0.2% 0.3% 0.1% 0.2% 0.3% 0.1% 0.2% 0.3%
QBD 1.2 1.6 2.8 1.4 1.8 3.0 11.2 13.8 18.3 10.3 13.4 20.2 9.8 13.1 24.2
QBO 1.1 2.0 3.0 1.3 1.6 2.9 10.3 12.9 16.9 8.8 11.9 18.6 7.8 11.8 22.3
[Zn(QBD)Cl2] 2.2 2.7 4.3 2.3 3.1 5.1 13.2 20.5 29.6 13.2 16.9 23.2 12.4 15.2 27.5
[Cd(QBD)Cl2] 1.8 2.4 3.9 2.0 2.8 4.3 12.9 18.5 25.6 12.1 16.0 22.4 11.3 14.3 26.3
[Co(QBD)2Cl2] 1.6 2.0 3.4 1.7 2.3 3.6 12.7 15.9 23.0 11.3 14.5 21.5 10.6 13.6 25.2
[Ni(QBD)2Cl2] 1.5 2.0 3.2 1.7 2.2 3.5 11.6 15.2 22.1 11.0 14.3 21.3 10.5 13.5 25.1
[Zn(QBO)Cl2] 1.8 3.2 4.2 2.1 2.9 4.3 12.3 19.8 28.5 11.5 14.9 21.1 10.2 14.4 25.3
[Cd(QBO)Cl2] 1.6 2.9 3.7 2.0 2.6 3.9 11.8 17.8 25.2 10.5 14.1 20.1 9.1 13.5 24.6
[Co(QBO)2Cl2] 1.5 2.6 3.5 1.6 2.2 3.4 11.1 15.6 22.0 9.8 13.0 19.3 8.6 12.9 23.4
[Ni(QBO)2Cl2] 1.5 2.5 3.5 1.6 2.1 3.3 11.1 14.9 21.5 9.7 12.9 19.2 8.5 12.8 23.2
S t r e p t o m y c i n4 . 0 1 2 . 0 1 3 . 5 9 . 4 1 4 . 5 2 6 . 7 —————————
F l u c o n a z o l e ————— — 3 6 . 2 5 5 . 5 7 0 . 0 3 6 . 0 4 0 . 0 6 5 . 8 3 7 . 5 4 8 . 9 7 5 . 4
DMF +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve +ve
DMF is used as control, +ve indicates growth of microbes.
T = average diameter of fungal growth on the tested plates
(Table 3).
Antibacterial and antifungal data are presented in
Table 3. This screening data clearly leads to the following
conclusion.
(i) Thecomplexesareslightlymoretoxicthantheirparent
ligands against tested microorganisms under identical
experimental conditions.
(ii) The antimicrobial activity results indicate that the ac-
tivity of Zn(II) complexes show better activity than
that of Cd(II), Co(II), and Ni(II) complexes.
(iii) Theantifungalscreeningdataclearlyshowsthatthein-
hibition of fungal growth increases with increasing the
concentration of complexes.
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